QIAGEN NV (QGEN)
50.17
-0.20
(-0.40%)
USD |
NYSE |
Oct 27, 16:00
50.19
+0.02
(+0.04%)
Pre-Market: 07:51
QIAGEN Enterprise Value : 11.21B for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 11.21B |
| October 26, 2026 | 11.25B |
| October 23, 2026 | 11.26B |
| October 22, 2026 | 11.22B |
| October 21, 2026 | 11.17B |
| October 20, 2026 | 10.95B |
| October 19, 2026 | 10.46B |
| October 16, 2026 | 10.38B |
| October 15, 2026 | 10.38B |
| October 14, 2026 | 10.26B |
| October 13, 2026 | 10.23B |
| October 12, 2026 | 10.21B |
| October 09, 2026 | 10.22B |
| October 08, 2026 | 10.05B |
| October 07, 2026 | 10.10B |
| October 06, 2026 | 10.28B |
| October 05, 2026 | 10.31B |
| October 02, 2026 | 10.09B |
| October 01, 2026 | 9.531B |
| September 30, 2026 | 9.886B |
| September 29, 2026 | 10.02B |
| September 28, 2026 | 10.14B |
| September 25, 2026 | 9.973B |
| September 24, 2026 | 10.05B |
| September 23, 2026 | 9.876B |
| Date | Value |
|---|---|
| September 22, 2026 | 9.872B |
| September 21, 2026 | 10.10B |
| September 18, 2026 | 9.798B |
| September 17, 2026 | 10.01B |
| September 16, 2026 | 9.709B |
| September 15, 2026 | 9.622B |
| September 14, 2026 | 9.498B |
| September 11, 2026 | 9.626B |
| September 10, 2026 | 9.550B |
| September 09, 2026 | 9.626B |
| September 08, 2026 | 9.601B |
| September 04, 2026 | 9.826B |
| September 03, 2026 | 9.907B |
| September 02, 2026 | 9.977B |
| September 01, 2026 | 9.810B |
| August 31, 2026 | 9.789B |
| August 28, 2026 | 9.752B |
| August 27, 2026 | 9.882B |
| August 26, 2026 | 9.804B |
| August 25, 2026 | 9.864B |
| August 24, 2026 | 9.477B |
| August 21, 2026 | 9.950B |
| August 20, 2026 | 10.12B |
| August 19, 2026 | 10.04B |
| August 18, 2026 | 9.589B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 291.68B |
| Illumina, Inc. | 43.56B |
| Agilent Technologies, Inc. | 52.24B |
| Bio-Rad Laboratories, Inc. | 9.937B |
| Waters Corp. | 50.94B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 103.40M |
| Revenue (Quarterly) | 535.04M |
| Total Expenses (Quarterly) | 431.64M |
| EPS Diluted (Quarterly) | 0.4975 |
| Gross Profit Margin (Quarterly) | 63.17% |
| Profit Margin (Quarterly) | 19.33% |
| Earnings Yield | 3.92% |
| Operating Earnings Yield | 4.96% |
| Normalized Earnings Yield | 4.428 |